Home LiteratureArticle Details
PMID: 22302935 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Review

NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Genes & development ·Vol. 26 ·No. 3 ·2012-02-01 ·Pages 203-34

Hayden MS, Ghosh S

Abstract

The ability to sense and adjust to the environment is crucial to life. For multicellular organisms, the ability to respond to external changes is essential not only for survival but also for normal development and physiology. Although signaling events can directly modify cellular function, typically signaling acts to alter transcriptional responses to generate both transient and sustained changes. Rapid, but transient, changes in gene expression are mediated by inducible transcription factors such as NF-κB. For the past 25 years, NF-κB has served as a paradigm for inducible transcription factors and has provided numerous insights into how signaling events influence gene expression and physiology. Since its discovery as a regulator of expression of the κ light chain gene in B cells, research on NF-κB continues to yield new insights into fundamental cellular processes. Advances in understanding the mechanisms that regulate NF-κB have been accompanied by progress in elucidating the biological significance of this transcription factor in various physiological processes. NF-κB likely plays the most prominent role in the development and function of the immune system and, not surprisingly, when dysregulated, contributes to the pathophysiology of inflammatory disease. As our appreciation of the fundamental role of inflammation in disease pathogenesis has increased, so too has the importance of NF-κB as a key regulatory molecule gained progressively greater significance. However, despite the tremendous progress that has been made in understanding the regulation of NF-κB, there is much that remains to be understood. In this review, we highlight both the progress that has been made and the fundamental questions that remain unanswered after 25 years of study.

MeSH Terms
Animals Enzyme Activation Gene Expression Regulation Humans Immune System/metabolism NF-kappa B/genetics,metabolism Signal Transduction
Chemicals
NF-kappa B
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hayden Matthew S
Department of Microbiology and Immunology, College of Physicians and Surgeons, New York, New York 10032, USA.
Ghosh Sankar
References (371)
371 references, click to expand
  1. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family.
    Cell. 1992 Mar 20;68(6):1109-20 PMID: 1339305
  2. NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation.
    J Biol Chem. 1998 Aug 14;273(33):21132-6 PMID: 9694868
  3. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome.
    Cell. 1998 Mar 20;92(6):819-28 PMID: 9529257
  4. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.
    Cell. 1990 Mar 23;60(6):991-7 PMID: 2180580
  5. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase.
    Nat Genet. 1999 May;22(1):74-7 PMID: 10319865
  6. NF-κB in immunobiology.
    Cell Res. 2011 Feb;21(2):223-44 PMID: 21243012
  7. Mapping of lysine monomethylation of linker histones in human breast and its cancer.
    J Proteome Res. 2009 Sep;8(9):4207-15 PMID: 19552482
  8. Cloning and functional characterization of mouse IkappaBepsilon.
    Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14372-7 PMID: 9405619
  9. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    EMBO J. 2008 Jan 23;27(2):373-83 PMID: 18079694
  10. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations.
    EMBO J. 1994 Oct 3;13(19):4597-607 PMID: 7925300
  11. Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation.
    J Biol Chem. 2006 May 12;281(19):13636-13643 PMID: 16543241
  12. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer.
    Nat Rev Cancer. 2010 Aug;10(8):561-74 PMID: 20651737
  13. Structural basis for the lack of E2 interaction in the RING domain of TRAF2.
    Biochemistry. 2009 Nov 10;48(44):10558-67 PMID: 19810754
  14. Direct phosphorylation of NF-kappaB1 p105 by the IkappaB kinase complex on serine 927 is essential for signal-induced p105 proteolysis.
    J Biol Chem. 2001 Jun 22;276(25):22215-22 PMID: 11297557
  15. X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex.
    J Biol Chem. 2003 Jun 20;278(25):23094-100 PMID: 12686541
  16. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors.
    Nat Immunol. 2008 Sep;9(9):1047-54 PMID: 18641653
  17. IL-17 signaling for mRNA stabilization does not require TNF receptor-associated factor 6.
    J Immunol. 2009 Feb 1;182(3):1660-6 PMID: 19155515
  18. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation.
    Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11778-83 PMID: 18697935
  19. Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins.
    Hum Mol Genet. 1994 May;3(5):793-9 PMID: 8081366
  20. Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation.
    Immunity. 2005 Dec;23(6):575-85 PMID: 16356856
  21. IkappaBeta, a nuclear IkappaB protein, positively regulates the NF-kappaB-mediated expression of proinflammatory cytokines.
    Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11924-9 PMID: 20547855
  22. Regulation of IkappaBbeta degradation. Similarities to and differences from IkappaBalpha.
    J Biol Chem. 1997 Apr 11;272(15):9942-9 PMID: 9092533
  23. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.
    Nat Immunol. 2004 May;5(5):503-7 PMID: 15064760
  24. IkappaB kinase is an essential component of the Tpl2 signaling pathway.
    Mol Cell Biol. 2004 Jul;24(13):6040-8 PMID: 15199157
  25. TAK1 is a central mediator of NOD2 signaling in epidermal cells.
    J Biol Chem. 2008 Jan 4;283(1):137-144 PMID: 17965022
  26. Structure, regulation and function of NF-kappa B.
    Annu Rev Cell Biol. 1994;10:405-55 PMID: 7888182
  27. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling.
    Nat Immunol. 2006 Sep;7(9):962-70 PMID: 16862162
  28. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
    Genes Dev. 1999 Apr 15;13(8):1015-24 PMID: 10215628
  29. Transcriptional regulation via the NF-kappaB signaling module.
    Oncogene. 2006 Oct 30;25(51):6706-16 PMID: 17072323
  30. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.
    Nat Immunol. 2011 Nov 06;12(12):1176-83 PMID: 22057290
  31. Function and activation of NF-kappa B in the immune system.
    Annu Rev Immunol. 1994;12:141-79 PMID: 8011280
  32. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis.
    J Clin Invest. 2011 Jan;121(1):265-76 PMID: 21157041
  33. TRAF6 is a signal transducer for interleukin-1.
    Nature. 1996 Oct 3;383(6599):443-6 PMID: 8837778
  34. Inhibitor kappaB kinase beta binding by inhibitor kappaB kinase gamma.
    Biochemistry. 2007 Oct 30;46(43):12482-90 PMID: 17924664
  35. IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15800-5 PMID: 14665694
  36. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes.
    Nature. 2000 Mar 23;404(6776):402-7 PMID: 10746729
  37. Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor.
    Mol Cell. 2002 Mar;9(3):637-48 PMID: 11931770
  38. Linear ubiquitination prevents inflammation and regulates immune signalling.
    Nature. 2011 Mar 31;471(7340):591-6 PMID: 21455173
  39. Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.
    J Invest Dermatol. 2011 Jan;131(1):141-9 PMID: 20811394
  40. When sirtuins and NF-kappaB collide.
    Cell. 2009 Jan 9;136(1):19-21 PMID: 19135883
  41. Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta.
    Biochem Biophys Res Commun. 2003 Feb 7;301(2):495-501 PMID: 12565889
  42. NF-kappaB as a critical link between inflammation and cancer.
    Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a000141 PMID: 20066113
  43. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2489-93 PMID: 1532257
  44. NF-kappa B regulates BCL3 transcription in T lymphocytes through an intronic enhancer.
    J Immunol. 2003 Oct 15;171(8):4210-8 PMID: 14530344
  45. Modulation of NF-kappaB activity by exchange of dimers.
    Mol Cell. 2003 Jun;11(6):1563-74 PMID: 12820969
  46. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.
    Cell. 1996 Jan 26;84(2):299-308 PMID: 8565075
  47. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.
    Nature. 1998 Sep 17;395(6699):297-300 PMID: 9751060
  48. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.
    Mol Cell. 2002 Mar;9(3):625-36 PMID: 11931769
  49. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.
    Genes Dev. 1999 Feb 1;13(3):270-83 PMID: 9990852
  50. Constitutive nuclear translocation of NF-kappa B in B cells in the absence of I kappa B degradation.
    J Immunol. 1999 Jul 1;163(1):269-77 PMID: 10384125
  51. Stabilization of RelB requires multidomain interactions with p100/p52.
    J Biol Chem. 2008 May 2;283(18):12324-32 PMID: 18321863
  52. The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity.
    Genes Dev. 1990 Nov;4(11):1975-84 PMID: 2125960
  53. Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.
    Genes Dev. 2006 Feb 1;20(3):282-96 PMID: 16452502
  54. Ubiquitin signalling in the NF-kappaB pathway.
    Nat Cell Biol. 2005 Aug;7(8):758-65 PMID: 16056267
  55. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
    Science. 2005 Apr 1;308(5718):114-8 PMID: 15802604
  56. Casper/c-FLIP is physically and functionally associated with NF-kappaB1 p105.
    Biochem Biophys Res Commun. 2003 Oct 3;309(4):980-5 PMID: 13679070
  57. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.
    Science. 1997 Oct 31;278(5339):866-9 PMID: 9346485
  58. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.
    Science. 1999 Apr 9;284(5412):321-5 PMID: 10195897
  59. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.
    EMBO J. 1997 Mar 17;16(6):1413-26 PMID: 9135156
  60. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.
    EMBO J. 2002 Dec 2;21(23):6539-48 PMID: 12456660
  61. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300.
    Mol Cell. 1998 Apr;1(5):661-71 PMID: 9660950
  62. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta.
    Mol Cell. 2009 Oct 23;36(2):302-14 PMID: 19854138
  63. SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.
    Nature. 2011 Mar 31;471(7340):633-6 PMID: 21455180
  64. FADD and the NF-kappaB family member Bcl-3 regulate complementary pathways to control T-cell survival and proliferation.
    Immunology. 2008 Dec;125(4):549-57 PMID: 18557791
  65. IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation.
    Immunity. 2006 Jan;24(1):41-51 PMID: 16413922
  66. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Cell. 2007 Nov 16;131(4):669-81 PMID: 18022362
  67. Functional characterization of NF-kappaB inhibitor-like protein 1 (NFkappaBIL1), a candidate susceptibility gene for rheumatoid arthritis.
    Hum Mol Genet. 2007 Dec 15;16(24):3027-36 PMID: 17855452
  68. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription.
    J Biol Chem. 2005 Dec 9;280(49):40450-64 PMID: 16204234
  69. Molecular determinants of NF-kappaB-inducing kinase action.
    Mol Cell Biol. 1998 Oct;18(10):5899-907 PMID: 9742107
  70. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
    Mol Cell. 2003 Dec;12(6):1413-26 PMID: 14690596
  71. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria.
    J Immunol. 2005 Mar 15;174(6):3650-7 PMID: 15749903
  72. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition.
    Mol Cell Biol. 2001 Dec;21(24):8428-36 PMID: 11713278
  73. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.
    N Engl J Med. 1997 Apr 10;336(15):1066-71 PMID: 9091804
  74. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation.
    Immunity. 2000 Apr;12(4):419-29 PMID: 10795740
  75. NEMO trimerizes through its coiled-coil C-terminal domain.
    J Biol Chem. 2002 May 17;277(20):17464-75 PMID: 11877453
  76. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages.
    Blood. 2003 Dec 1;102(12):4123-9 PMID: 12907458
  77. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
    Nat Cell Biol. 2005 Sep;7(9):921-3 PMID: 16136188
  78. Identification of a ZU5 and death domain-containing inhibitor of NF-kappaB.
    J Biol Chem. 2004 Apr 23;279(17):17819-25 PMID: 14769797
  79. I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B.
    Cell. 1995 Feb 24;80(4):573-82 PMID: 7867065
  80. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
    Genes Dev. 1993 Nov;7(11):2064-70 PMID: 8224838
  81. Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation.
    Nat Immunol. 2009 Jan;10(1):38-47 PMID: 19060899
  82. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.
    Nat Cell Biol. 2004 Feb;6(2):97-105 PMID: 14743216
  83. Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 Fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.
    Mol Cell Biol. 2004 Jan;24(1):475-86 PMID: 14673179
  84. Phosphorylation of p105 PEST sequence via a redox-insensitive pathway up-regulates processing of p50 NF-kappaB.
    J Biol Chem. 1996 Mar 15;271(11):6084-91 PMID: 8626394
  85. Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.
    Nucleic Acids Res. 1993 Nov 11;21(22):5059-66 PMID: 8255759
  86. Introduction to NF-kappaB: players, pathways, perspectives.
    Oncogene. 2006 Oct 30;25(51):6680-4 PMID: 17072321
  87. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
    EMBO J. 2001 Mar 15;20(6):1271-80 PMID: 11250893
  88. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
    J Biol Chem. 2010 May 28;285(22):17148-55 PMID: 20348096
  89. Functional role for I kappa BNS in T cell cytokine regulation as revealed by targeted gene disruption.
    J Immunol. 2007 Aug 1;179(3):1681-92 PMID: 17641034
  90. TIR domain-containing adaptors define the specificity of TLR signaling.
    Mol Immunol. 2004 Feb;40(12):861-8 PMID: 14698224
  91. Roles for homotypic interactions and transautophosphorylation in IkappaB kinase beta IKKbeta) activation [corrected].
    J Biol Chem. 2003 Oct 3;278(40):38566-70 PMID: 12890679
  92. The logic of chromatin architecture and remodelling at promoters.
    Nature. 2009 Sep 10;461(7261):193-8 PMID: 19741699
  93. Identification of the MMS22L-TONSL complex that promotes homologous recombination.
    Mol Cell. 2010 Nov 24;40(4):632-44 PMID: 21055984
  94. Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100.
    J Biol Chem. 2005 Mar 18;280(11):9765-8 PMID: 15677466
  95. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice.
    Immunity. 1999 Apr;10(4):421-9 PMID: 10229185
  96. Expanding TRAF function: TRAF3 as a tri-faced immune regulator.
    Nat Rev Immunol. 2011 Jun 10;11(7):457-68 PMID: 21660053
  97. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176.
    Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3792-7 PMID: 9520446
  98. Inhibitor of kappa B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells.
    PLoS One. 2011;6(9):e24504 PMID: 21915344
  99. Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms.
    Genes Dev. 2008 May 1;22(9):1159-73 PMID: 18408078
  100. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.
    Science. 2002 Nov 8;298(5596):1241-5 PMID: 12424381
  101. A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells.
    Nat Immunol. 2011 May 22;12(7):647-54 PMID: 21602810
  102. SHARPIN is an endogenous inhibitor of β1-integrin activation.
    Nat Cell Biol. 2011 Sep 25;13(11):1315-24 PMID: 21947080
  103. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
    EMBO J. 1993 Oct;12(10):3893-901 PMID: 8404857
  104. RNAi-based screening identifies the Mms22L-Nfkbil2 complex as a novel regulator of DNA replication in human cells.
    EMBO J. 2010 Dec 15;29(24):4210-22 PMID: 21113133
  105. beta-TrCP mediates the signal-induced ubiquitination of IkappaBbeta.
    J Biol Chem. 1999 Oct 15;274(42):29591-4 PMID: 10514424
  106. Impact of TNF-R1 and CD95 internalization on apoptotic and antiapoptotic signaling.
    Results Probl Cell Differ. 2009;49:63-85 PMID: 19132322
  107. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction.
    Mol Cell. 2009 Dec 11;36(5):831-44 PMID: 20005846
  108. Non-canonical NF-κB signaling pathway.
    Cell Res. 2011 Jan;21(1):71-85 PMID: 21173796
  109. Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA.
    J Biol Chem. 1997 Dec 26;272(52):33132-9 PMID: 9407099
  110. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death.
    J Biol Chem. 2001 Sep 28;276(39):36530-4 PMID: 11479302
  111. Dynamic and selective nucleosome repositioning during endotoxin tolerance.
    J Biol Chem. 2010 Jan 8;285(2):1259-71 PMID: 19901031
  112. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate.
    Science. 1998 Aug 28;281(5381):1360-3 PMID: 9721103
  113. IL-17 enhances chemokine gene expression through mRNA stabilization.
    J Immunol. 2007 Sep 15;179(6):4135-41 PMID: 17785852
  114. Activators and target genes of Rel/NF-kappaB transcription factors.
    Oncogene. 1999 Nov 22;18(49):6853-66 PMID: 10602461
  115. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Nat Cell Biol. 2006 Apr;8(4):398-406 PMID: 16547522
  116. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
    Oncogene. 2006 Oct 30;25(51):6781-99 PMID: 17072328
  117. Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase.
    Biochem J. 2000 Mar 15;346 Pt 3:641-9 PMID: 10698690
  118. Mutations in the NF-kappaB signaling pathway: implications for human disease.
    Oncogene. 2006 Oct 30;25(51):6831-43 PMID: 17072331
  119. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Mol Cell. 2004 May 7;14(3):289-301 PMID: 15125833
  120. Functional complementation between FADD and RIP1 in embryos and lymphocytes.
    Nature. 2011 Mar 17;471(7338):373-6 PMID: 21368761
  121. Inhibition of NF-kappa B by S-nitrosylation.
    Biochemistry. 2001 Feb 13;40(6):1688-93 PMID: 11327828
  122. vCLAP, a caspase-recruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma.
    J Biol Chem. 2001 Feb 2;276(5):3183-7 PMID: 11113112
  123. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
    Cell. 1989 Jul 28;58(2):227-9 PMID: 2665943
  124. MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production.
    FEBS Lett. 2000 Nov 17;485(1):53-6 PMID: 11086164
  125. Modification of proteins by ubiquitin and ubiquitin-like proteins.
    Annu Rev Cell Dev Biol. 2006;22:159-80 PMID: 16753028
  126. Hierarchies of NF-κB target-gene regulation.
    Nat Immunol. 2011 Jul 19;12(8):689-94 PMID: 21772277
  127. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.
    J Immunol. 2010 Aug 1;185(3):1894-902 PMID: 20610652
  128. betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932.
    Mol Cell Biol. 2003 Jan;23(1):402-13 PMID: 12482991
  129. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation.
    J Biol Chem. 2005 Nov 4;280(44):36560-6 PMID: 16115877
  130. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
    Genes Dev. 1991 Aug;5(8):1464-76 PMID: 1907941
  131. NFKBIL1 confers resistance to experimental autoimmune arthritis through the regulation of dendritic cell functions.
    Scand J Immunol. 2011 May;73(5):478-85 PMID: 21284685
  132. Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding.
    Nat Immunol. 2011 Nov 20;13(1):95-102 PMID: 22101729
  133. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice.
    Genes Dev. 1995 Nov 15;9(22):2736-46 PMID: 7590249
  134. IKK regulation and human genetics.
    Curr Top Microbiol Immunol. 2011;349:73-95 PMID: 20845108
  135. Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B.
    Mol Cell Biol. 1996 Oct;16(10):5444-9 PMID: 8816457
  136. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
    Immunity. 2003 Nov;19(5):749-58 PMID: 14614861
  137. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation.
    Cell. 1998 Jun 26;93(7):1231-40 PMID: 9657155
  138. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.
    Genes Dev. 1993 Jul;7(7B):1354-63 PMID: 8330739
  139. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.
    Science. 1999 Apr 9;284(5412):309-13 PMID: 10195894
  140. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.
    Immunity. 1997 Nov;7(5):715-25 PMID: 9390694
  141. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).
    Nat Immunol. 2011 Aug 07;12(9):853-60 PMID: 21822258
  142. Isolation, sequence, and chromosomal localisation of the human IkappaBR gene (NFKBIL2).
    Ann Hum Genet. 2000 Jan;64(Pt 1):15-23 PMID: 11246458
  143. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance.
    J Biol Chem. 2007 Sep 14;282(37):26857-26864 PMID: 17646159
  144. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
    J Biol Chem. 2001 Jul 20;276(29):26769-76 PMID: 11350967
  145. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
    Science. 2001 Aug 24;293(5534):1495-9 PMID: 11520989
  146. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor.
    J Biol Chem. 2006 Nov 24;281(47):35603-7 PMID: 17035243
  147. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
    EMBO J. 2006 May 3;25(9):1945-56 PMID: 16619030
  148. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.
    Cell. 1993 Mar 12;72(5):729-39 PMID: 8453667
  149. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.
    Mol Cell. 2006 Apr 21;22(2):245-57 PMID: 16603398
  150. Direct activation of protein kinases by unanchored polyubiquitin chains.
    Nature. 2009 Sep 3;461(7260):114-9 PMID: 19675569
  151. Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses.
    Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11536-41 PMID: 21709223
  152. NEMO/IKK gamma-deficient mice model incontinentia pigmenti.
    Mol Cell. 2000 Jun;5(6):981-92 PMID: 10911992
  153. beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870.
    Cell Signal. 2006 Aug;18(8):1309-17 PMID: 16303288
  154. Immunological adjuvants promote activated T cell survival via induction of Bcl-3.
    Nat Immunol. 2001 May;2(5):397-402 PMID: 11323692
  155. Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells.
    J Immunol. 2005 Jan 15;174(2):600-4 PMID: 15634875
  156. Limb and skin abnormalities in mice lacking IKKalpha.
    Science. 1999 Apr 9;284(5412):313-6 PMID: 10195895
  157. SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.
    EMBO J. 2000 Jun 1;19(11):2580-91 PMID: 10835356
  158. NF-κB, inflammation, and metabolic disease.
    Cell Metab. 2011 Jan 5;13(1):11-22 PMID: 21195345
  159. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade.
    Science. 2007 Aug 3;317(5838):675-8 PMID: 17673665
  160. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells.
    Nat Immunol. 2009 Feb;10(2):158-66 PMID: 19122654
  161. Structure and signalling in the IL-17 receptor family.
    Nat Rev Immunol. 2009 Aug;9(8):556-67 PMID: 19575028
  162. Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.
    Cell Res. 2011 Jan;21(1):131-45 PMID: 21135874
  163. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity.
    Cell. 2010 Apr 16;141(2):315-30 PMID: 20403326
  164. A bivalent chromatin structure marks key developmental genes in embryonic stem cells.
    Cell. 2006 Apr 21;125(2):315-26 PMID: 16630819
  165. Crosstalk in NF-κB signaling pathways.
    Nat Immunol. 2011 Jul 19;12(8):695-708 PMID: 21772278
  166. Nucleosome-interacting proteins regulated by DNA and histone methylation.
    Cell. 2010 Oct 29;143(3):470-84 PMID: 21029866
  167. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
    Science. 2001 Aug 31;293(5535):1653-7 PMID: 11533489
  168. Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP.
    J Biol Chem. 1999 Mar 19;274(12):7941-5 PMID: 10075690
  169. Crystal structure of inhibitor of κB kinase β.
    Nature. 2011 Apr 21;472(7343):325-30 PMID: 21423167
  170. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase.
    Nature. 1998 Dec 10;396(6711):590-4 PMID: 9859996
  171. A special issue on NF-κB signaling and function.
    Cell Res. 2011 Jan;21(1):1-2 PMID: 21196938
  172. IKK1-deficient mice exhibit abnormal development of skin and skeleton.
    Genes Dev. 1999 May 15;13(10):1322-8 PMID: 10346820
  173. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Genes Dev. 1995 Nov 15;9(22):2723-35 PMID: 7590248
  174. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
    Mol Cell Biol. 2006 Jan;26(2):457-71 PMID: 16382138
  175. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.
    Nature. 1993 Sep 9;365(6442):182-5 PMID: 8371761
  176. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
    Nature. 1990 Apr 12;344(6267):678-82 PMID: 2157987
  177. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors.
    Mol Cell Biol. 2000 May;20(10):3407-16 PMID: 10779330
  178. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
    EMBO J. 2004 Jan 28;23(2):322-32 PMID: 14713952
  179. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
    Cell. 2007 Nov 16;131(4):682-93 PMID: 18022363
  180. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.
    Nature. 1997 Aug 7;388(6642):548-54 PMID: 9252186
  181. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages.
    J Biol Chem. 2004 Nov 26;279(48):49995-50003 PMID: 15465827
  182. The molecular basis of eukaryotic transcription.
    Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):12955-61 PMID: 17670940
  183. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.
    Cell. 2009 Mar 20;136(6):1098-109 PMID: 19303852
  184. Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity.
    Mol Cell Biol. 2006 Dec;26(24):9209-19 PMID: 17000764
  185. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
    Nature. 2004 Jul 8;430(6996):218-22 PMID: 15241416
  186. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.
    Immunity. 1997 Dec;7(6):837-47 PMID: 9430229
  187. Phosphorylation of the CARMA1 linker controls NF-kappaB activation.
    Immunity. 2005 Dec;23(6):561-74 PMID: 16356855
  188. NOS2 regulation of NF-kappaB by S-nitrosylation of p65.
    J Biol Chem. 2007 Oct 19;282(42):30667-72 PMID: 17720813
  189. Receptor-interacting protein (RIP) kinase family.
    Cell Mol Immunol. 2010 Jul;7(4):243-9 PMID: 20383176
  190. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.
    Immunity. 1998 Mar;8(3):297-303 PMID: 9529147
  191. The signaling adaptors and pathways activated by TNF superfamily.
    Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):193-209 PMID: 12787559
  192. Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha.
    Mol Cell Biol. 2001 Feb;21(4):1024-35 PMID: 11158290
  193. In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8.
    J Biol Chem. 2011 Apr 15;286(15):13282-91 PMID: 21339290
  194. NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence.
    J Biol Chem. 2001 Aug 24;276(34):32080-93 PMID: 11387332
  195. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors.
    Nature. 2010 Apr 29;464(7293):1381-5 PMID: 20383124
  196. Identification and characterization of an IkappaB kinase.
    Cell. 1997 Jul 25;90(2):373-83 PMID: 9244310
  197. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.
    Mol Cell. 2001 Feb;7(2):401-9 PMID: 11239468
  198. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP.
    Genes Dev. 1999 Feb 1;13(3):284-94 PMID: 9990853
  199. Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta.
    J Exp Med. 1998 Sep 21;188(6):1055-62 PMID: 9743524
  200. A chromatin landmark and transcription initiation at most promoters in human cells.
    Cell. 2007 Jul 13;130(1):77-88 PMID: 17632057
  201. Role of NF-κB in the skeleton.
    Cell Res. 2011 Jan;21(1):169-82 PMID: 21079651
  202. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.
    Science. 1997 Oct 31;278(5339):860-6 PMID: 9346484
  203. The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation.
    Genes Dev. 2003 Apr 1;17(7):873-82 PMID: 12654725
  204. Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors.
    Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12429-34 PMID: 18719121
  205. IkappaB-zeta, a new anti-inflammatory nuclear protein induced by lipopolysaccharide, is a negative regulator for nuclear factor-kappaB.
    J Endotoxin Res. 2003;9(3):187-91 PMID: 12831461
  206. Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.
    Mol Cell Biol. 1996 Apr;16(4):1342-8 PMID: 8657107
  207. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex.
    Mol Cell Biol. 1999 Feb;19(2):1526-38 PMID: 9891086
  208. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
    Nature. 1992 Aug 13;358(6387):597-9 PMID: 1501714
  209. Tyrosine nitration on p65: a novel mechanism to rapidly inactivate nuclear factor-kappaB.
    Mol Cell Proteomics. 2005 Mar;4(3):300-9 PMID: 15657065
  210. Characterization of the nuclear import and export functions of Ikappa B(epsilon).
    J Biol Chem. 2002 Jun 28;277(26):23358-66 PMID: 11970947
  211. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response.
    Blood. 2006 May 1;107(9):3656-64 PMID: 16410444
  212. Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation.
    Mol Cell Biol. 2003 Mar;23(6):2029-41 PMID: 12612076
  213. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family.
    EMBO J. 1993 Dec 15;12(13):5043-9 PMID: 8262046
  214. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.
    EMBO J. 2007 Jan 24;26(2):436-47 PMID: 17183367
  215. A role for phosphorylation in the proteolytic processing of the human NF-kappa B1 precursor.
    Gene. 1995 Nov 20;165(2):183-9 PMID: 8522173
  216. Reductions in I kappa B epsilon and changes in NF-kappa B activity during B lymphocyte differentiation.
    J Immunol. 2005 Jan 15;174(2):983-91 PMID: 15634922
  217. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation.
    EMBO J. 2003 Aug 1;22(15):3910-8 PMID: 12881425
  218. Induction of RelB participates in endotoxin tolerance.
    J Immunol. 2006 Sep 15;177(6):4080-5 PMID: 16951372
  219. IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo.
    J Exp Med. 2010 Nov 22;207(12):2621-30 PMID: 20975042
  220. Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice.
    J Biol Chem. 2008 May 23;283(21):14182-9 PMID: 18375954
  221. Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease.
    Genes Dev. 2010 Aug 15;24(16):1709-17 PMID: 20713516
  222. Linear polyubiquitylation: the missing link in NF-kappaB signalling.
    Nat Cell Biol. 2009 Feb;11(2):116-8 PMID: 19188917
  223. Functional isoforms of IkappaB kinase alpha (IKKalpha) lacking leucine zipper and helix-loop-helix domains reveal that IKKalpha and IKKbeta have different activation requirements.
    Mol Cell Biol. 2000 Apr;20(8):2635-49 PMID: 10733566
  224. IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.
    Nature. 2010 Aug 26;466(7310):1115-9 PMID: 20740013
  225. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.
    J Biol Chem. 2004 Jul 16;279(29):30099-105 PMID: 15140882
  226. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  227. Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity.
    Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9619-24 PMID: 19487661
  228. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.
    EMBO J. 2007 Nov 14;26(22):4634-45 PMID: 17948050
  229. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
    Nat Immunol. 2008 Dec;9(12):1364-70 PMID: 18997792
  230. Inflammation meets cancer, with NF-κB as the matchmaker.
    Nat Immunol. 2011 Jul 19;12(8):715-23 PMID: 21772280
  231. Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
    Science. 2003 Nov 28;302(5650):1581-4 PMID: 14576442
  232. The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1.
    J Biol Chem. 2001 Dec 14;276(50):47664-70 PMID: 11577079
  233. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
    J Biol Chem. 2007 Mar 23;282(12):8724-33 PMID: 17244613
  234. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
    J Biol Chem. 2004 Apr 30;279(18):18137-45 PMID: 14963024
  235. Regulation of NF-kappaB activity through lysine monomethylation of p65.
    Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):18972-7 PMID: 19864627
  236. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
    J Biol Chem. 2004 Jun 18;279(25):26243-50 PMID: 15084608
  237. RelA control of IkappaBalpha phosphorylation: a positive feedback loop for high affinity NF-kappaB complexes.
    J Biol Chem. 2003 Aug 15;278(33):30881-8 PMID: 12663663
  238. Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon.
    J Biol Chem. 2006 Aug 11;281(32):22624-34 PMID: 16769727
  239. A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability.
    Mol Cell. 2010 Nov 24;40(4):645-57 PMID: 21055985
  240. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase.
    Science. 1999 Apr 9;284(5412):316-20 PMID: 10195896
  241. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.
    Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9803-8 PMID: 10449775
  242. A high-resolution map of active promoters in the human genome.
    Nature. 2005 Aug 11;436(7052):876-80 PMID: 15988478
  243. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.
    Mol Cell Biol. 2003 Jul;23(13):4713-27 PMID: 12808109
  244. A ubiquitin ligase complex assembles linear polyubiquitin chains.
    EMBO J. 2006 Oct 18;25(20):4877-87 PMID: 17006537
  245. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.
    Semin Immunol. 2000 Feb;12(1):85-98 PMID: 10723801
  246. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
    Oncogene. 2006 Nov 23;25(55):7297-304 PMID: 16732314
  247. The precursor of NF-kappa B p50 has I kappa B-like functions.
    Cell. 1992 Oct 16;71(2):243-53 PMID: 1423592
  248. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation.
    Immunity. 2000 Mar;12(3):301-11 PMID: 10755617
  249. Regulation of IkappaB beta in WEHI 231 mature B cells.
    Mol Cell Biol. 1997 Aug;17(8):4390-6 PMID: 9234697
  250. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.
    Cell. 1995 Jan 27;80(2):331-40 PMID: 7834753
  251. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
    Cell. 2006 May 19;125(4):665-77 PMID: 16713561
  252. Missing pieces in the NF-kappaB puzzle.
    Cell. 2002 Apr;109 Suppl:S81-96 PMID: 11983155
  253. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation.
    Mol Cell. 2010 Oct 8;40(1):63-74 PMID: 20932475
  254. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.
    Annu Rev Immunol. 1998;16:225-60 PMID: 9597130
  255. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation.
    Nat Immunol. 2011 Aug 07;12(9):844-52 PMID: 21822257
  256. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.
    Genes Dev. 2000 Apr 1;14(7):854-62 PMID: 10766741
  257. Signaling to NF-kappaB.
    Genes Dev. 2004 Sep 15;18(18):2195-224 PMID: 15371334
  258. Distinct molecular mechanism for initiating TRAF6 signalling.
    Nature. 2002 Jul 25;418(6896):443-7 PMID: 12140561
  259. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains.
    J Biol Chem. 2004 Jul 2;279(27):27861-9 PMID: 15107419
  260. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription.
    Immunity. 1999 Dec;11(6):665-75 PMID: 10626889
  261. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
    Mol Cell Biol. 1993 Jun;13(6):3557-66 PMID: 8497270
  262. Type 2 diabetes as an inflammatory disease.
    Nat Rev Immunol. 2011 Feb;11(2):98-107 PMID: 21233852
  263. Nuclear factor-kappaB in cancer development and progression.
    Nature. 2006 May 25;441(7092):431-6 PMID: 16724054
  264. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  265. IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression.
    J Cell Biol. 2006 Jun 5;173(5):659-64 PMID: 16735576
  266. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.
    Oncogene. 1999 Mar 25;18(12):2039-46 PMID: 10321728
  267. IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.
    J Exp Med. 2007 Dec 24;204(13):3285-93 PMID: 18086859
  268. Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.
    J Biol Chem. 1998 Nov 6;273(45):29411-6 PMID: 9792644
  269. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways.
    J Biol Chem. 2000 Sep 8;275(36):27823-31 PMID: 10880512
  270. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Genes Dev. 1993 Apr;7(4):705-18 PMID: 8458581
  271. A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei.
    J Biol Chem. 2001 Jul 20;276(29):27657-62 PMID: 11356851
  272. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase.
    Oncogene. 2004 Apr 1;23(14):2540-7 PMID: 14676825
  273. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Cell. 1994 Sep 9;78(5):773-85 PMID: 8087845
  274. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.
    J Biol Chem. 2003 Sep 19;278(38):36916-23 PMID: 12842894
  275. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.
    Genes Dev. 2000 Jul 15;14(14):1729-33 PMID: 10898787
  276. NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule.
    Mol Cell Biol. 1993 Oct;13(10):6089-101 PMID: 8413211
  277. NF-kappaB RelA phosphorylation regulates RelA acetylation.
    Mol Cell Biol. 2005 Sep;25(18):7966-75 PMID: 16135789
  278. Cloning of a differentially expressed I kappa B-related protein.
    J Biol Chem. 1995 May 5;270(18):10680-5 PMID: 7738005
  279. Common pathway for the ubiquitination of IkappaBalpha, IkappaBbeta, and IkappaBepsilon mediated by the F-box protein FWD1.
    J Biol Chem. 1999 Oct 1;274(40):28169-74 PMID: 10497169
  280. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.
    J Biol Chem. 2000 Oct 20;275(42):32592-7 PMID: 10938077
  281. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.
    Cell. 1997 Oct 17;91(2):243-52 PMID: 9346241
  282. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.
    Mol Cell Biol. 2004 Nov;24(21):9658-67 PMID: 15485931
  283. Molecular mechanism of TNF signaling and beyond.
    Cell Res. 2005 Jan;15(1):24-7 PMID: 15686622
  284. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism.
    Cell. 1997 May 2;89(3):413-24 PMID: 9150141
  285. A fourth IkappaB protein within the NF-kappaB signaling module.
    Cell. 2007 Jan 26;128(2):369-81 PMID: 17254973
  286. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.
    Sci STKE. 1999 Oct 26;1999(5):RE1 PMID: 11865184
  287. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation.
    Nat Cell Biol. 2009 Feb;11(2):123-32 PMID: 19136968
  288. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
    EMBO J. 1993 Jan;12(1):213-22 PMID: 8428580
  289. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit.
    Nat Immunol. 2007 Jun;8(6):584-91 PMID: 17468759
  290. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
    Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3503-8 PMID: 18292232
  291. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3.
    J Biol Chem. 2007 Sep 28;282(39):28335-28343 PMID: 17644518
  292. DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.
    Cell. 1991 Mar 8;64(5):961-9 PMID: 2001591
  293. Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway.
    Nature. 1991 Dec 5;354(6352):395-8 PMID: 1956402
  294. IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2.
    Biochem Biophys Res Commun. 1999 Mar 5;256(1):127-32 PMID: 10066435
  295. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization.
    J Biol Chem. 2005 Jan 14;280(2):1678-87 PMID: 15522867
  296. Isolation of a novel interleukin-1-inducible nuclear protein bearing ankyrin-repeat motifs.
    J Biol Chem. 2001 Apr 20;276(16):12485-8 PMID: 11278262
  297. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.
    Cell Death Differ. 2010 Mar;17(3):482-7 PMID: 19927158
  298. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Genes Dev. 1995 Jul 1;9(13):1586-97 PMID: 7628694
  299. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation.
    Biochem Biophys Res Commun. 1997 Sep 29;238(3):703-6 PMID: 9325152
  300. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.
    Mol Cell Biol. 1996 May;16(5):2341-9 PMID: 8628301
  301. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.
    J Exp Med. 1999 Jun 7;189(11):1839-45 PMID: 10359587
  302. A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.
    Mol Cell Biol. 1996 May;16(5):2248-54 PMID: 8628291
  303. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
    EMBO J. 1999 Sep 1;18(17):4766-78 PMID: 10469655
  304. Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.
    Oncogene. 1996 Jun 6;12(11):2385-92 PMID: 8649779
  305. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.
    EMBO J. 1996 Nov 15;15(22):6189-96 PMID: 8947041
  306. RIP links TLR4 to Akt and is essential for cell survival in response to LPS stimulation.
    J Exp Med. 2004 Aug 2;200(3):399-404 PMID: 15280422
  307. The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells.
    Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10979-84 PMID: 16832056
  308. The nuclear factor NF-kappaB pathway in inflammation.
    Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651 PMID: 20457564
  309. NF-kappaB signals induce the expression of c-FLIP.
    Mol Cell Biol. 2001 Aug;21(16):5299-305 PMID: 11463813
  310. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway.
    J Mol Biol. 2003 Feb 7;326(1):105-15 PMID: 12547194
  311. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis.
    Nature. 2011 Mar 31;471(7340):637-41 PMID: 21455181
  312. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B.
    EMBO J. 1993 Jul;12(7):2773-9 PMID: 8334993
  313. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization.
    Mol Cell. 2007 Jun 8;26(5):689-702 PMID: 17560374
  314. Stimulation of IKK-gamma oligomerization by the human T-cell leukemia virus oncoprotein Tax.
    FEBS Lett. 2002 Nov 20;531(3):494-8 PMID: 12435599
  315. The RIP kinases: crucial integrators of cellular stress.
    Trends Biochem Sci. 2005 Mar;30(3):151-9 PMID: 15752987
  316. A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase.
    J Biol Chem. 2004 Oct 29;279(44):45528-39 PMID: 15319427
  317. IL-1-induced post-transcriptional mechanisms target overlapping translational silencing and destabilizing elements in IκBζ mRNA.
    J Biol Chem. 2010 Sep 17;285(38):29165-78 PMID: 20634286
  318. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
    J Exp Med. 2004 Jul 5;200(1):107-13 PMID: 15226358
  319. Complete reconstitution of human IkappaB kinase (IKK) complex in yeast. Assessment of its stoichiometry and the role of IKKgamma on the complex activity in the absence of stimulation.
    J Biol Chem. 2001 Sep 28;276(39):36320-6 PMID: 11470787
  320. Bcl3 interacts cooperatively with peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha to coactivate nuclear receptors estrogen-related receptor alpha and PPARalpha.
    Mol Cell Biol. 2009 Aug;29(15):4091-102 PMID: 19451226
  321. Distinct functional properties of IkappaB alpha and IkappaB beta.
    Mol Cell Biol. 1997 Sep;17(9):5386-99 PMID: 9271416
  322. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice.
    Genes Cells. 1999 Jun;4(6):353-62 PMID: 10421844
  323. Regulation and function of IKK and IKK-related kinases.
    Sci STKE. 2006 Oct 17;2006(357):re13 PMID: 17047224
  324. Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105.
    Oncogene. 1999 Jan 28;18(4):995-1005 PMID: 10023675
  325. Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein.
    J Biol Chem. 2005 Mar 4;280(9):7444-51 PMID: 15618216
  326. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2532-6 PMID: 8460169
  327. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time.
    Nat Immunol. 2005 May;6(5):439-45 PMID: 15843800
  328. Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization.
    J Biol Chem. 2000 Dec 1;275(48):37966-77 PMID: 10980203
  329. A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.
    Genes Dev. 2005 Sep 15;19(18):2138-51 PMID: 16166378
  330. The I kappa B kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component.
    J Biol Chem. 2000 Sep 22;275(38):29779-87 PMID: 10893415
  331. Immunological defects in mice with a targeted disruption in Bcl-3.
    Genes Dev. 1997 Jan 15;11(2):187-97 PMID: 9009202
  332. Systematic in vivo structure-function analysis of p300 in hematopoiesis.
    Blood. 2009 Nov 26;114(23):4804-12 PMID: 19822904
  333. Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export.
    Mol Cell Biol. 2000 Mar;20(6):2269-84 PMID: 10688673
  334. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.
    J Biol Chem. 2008 Jan 4;283(1):76-86 PMID: 17977820
  335. Ubiquitylation in innate and adaptive immunity.
    Nature. 2009 Mar 26;458(7237):430-7 PMID: 19325622
  336. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions.
    Immunity. 1997 Apr;6(4):479-90 PMID: 9133427
  337. Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB.
    Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6662-7 PMID: 21464294
  338. The MMS22L-TONSL complex mediates recovery from replication stress and homologous recombination.
    Mol Cell. 2010 Nov 24;40(4):619-31 PMID: 21055983
  339. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses.
    Nat Immunol. 2008 Sep;9(9):1037-46 PMID: 18641654
  340. NF-κB in the regulation of epithelial homeostasis and inflammation.
    Cell Res. 2011 Jan;21(1):146-58 PMID: 21151201
  341. Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.
    Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1042-7 PMID: 9927690
  342. Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.
    Mol Cell Biol. 1999 May;19(5):3664-73 PMID: 10207090
  343. Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit.
    J Biol Chem. 1997 Dec 19;272(51):32606-12 PMID: 9405476
  344. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10599-603 PMID: 7479848
  345. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.
    EMBO J. 1995 May 1;14(9):1991-2004 PMID: 7744006
  346. Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-kappa B2/p100.
    J Biol Chem. 2002 Jun 21;277(25):22111-4 PMID: 11994270
  347. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.
    J Biol Chem. 2002 Feb 8;277(6):3863-9 PMID: 11733537
  348. S9, a 19 S proteasome subunit interacting with ubiquitinated NF-kappaB2/p100.
    J Biol Chem. 2002 Oct 25;277(43):40697-702 PMID: 12185077
  349. The histone octamer is invisible when NF-kappaB binds to the nucleosome.
    J Biol Chem. 2004 Oct 8;279(41):42374-82 PMID: 15269206
  350. Shared principles in NF-kappaB signaling.
    Cell. 2008 Feb 8;132(3):344-62 PMID: 18267068
  351. Targeted disruption of MAIL, a nuclear IkappaB protein, leads to severe atopic dermatitis-like disease.
    J Biol Chem. 2004 Dec 31;279(53):55493-8 PMID: 15491998
  352. The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB.
    J Mol Biol. 2010 Feb 26;396(3):528-39 PMID: 20064526
  353. Regulation of naive T cell function by the NF-kappaB2 pathway.
    Nat Immunol. 2006 Jul;7(7):763-72 PMID: 16732290
  354. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.
    J Biol Chem. 2004 Aug 6;279(32):33185-91 PMID: 15175328
  355. Identification of RIP1 kinase as a specific cellular target of necrostatins.
    Nat Chem Biol. 2008 May;4(5):313-21 PMID: 18408713
  356. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).
    EMBO J. 2003 Mar 17;22(6):1313-24 PMID: 12628924
  357. Linear ubiquitination in NF-κB signaling and inflammation: What we do understand and what we do not.
    Biochem Pharmacol. 2011 Nov 1;82(9):1057-65 PMID: 21787758
  358. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
    J Exp Med. 2006 Oct 30;203(11):2413-8 PMID: 17015635
  359. Deubiquitinases in the regulation of NF-κB signaling.
    Cell Res. 2011 Jan;21(1):22-39 PMID: 21119682
  360. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria.
    Nat Immunol. 2000 Aug;1(2):113-8 PMID: 11248802
  361. PIDD mediates NF-kappaB activation in response to DNA damage.
    Cell. 2005 Dec 16;123(6):1079-92 PMID: 16360037
  362. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B.
    Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):552-6 PMID: 7831327
  363. Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation.
    Blood. 2004 Jun 15;103(12):4573-80 PMID: 14764534
  364. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis.
    Immunity. 2001 Mar;14(3):217-30 PMID: 11290332
  365. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response.
    Cell. 2011 Aug 5;146(3):448-61 PMID: 21782231
  366. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
    Mol Cell Biol. 2007 Sep;27(17):6012-25 PMID: 17562858
  367. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event.
    Nat Immunol. 2001 Jan;2(1):51-7 PMID: 11135578
  368. TNFR1-induced activation of the classical NF-κB pathway.
    FEBS J. 2011 Apr;278(6):862-76 PMID: 21232017
  369. The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter.
    J Virol. 2008 Dec;82(23):11939-47 PMID: 18815299
  370. RelB cellular regulation and transcriptional activity are regulated by p100.
    J Biol Chem. 2002 Jan 11;277(2):1405-18 PMID: 11687592
  371. Two waves of nuclear factor kappaB recruitment to target promoters.
    J Exp Med. 2001 Jun 18;193(12):1351-9 PMID: 11413190
Article Info
Journal
Genes & development
Abbr.
Genes Dev
ISSN
1549-5477
Published
2012-02-01
Pages
203-34
Language
English
Region
United States
NLM ID
8711660
PMCID
PMC3278889
Subset
IM
Grants
NIAID NIH HHS · AI093985 · United States
NIAID NIH HHS · AI068977 · United States
NIAMS NIH HHS · P30AR058886 · United States
NIAID NIH HHS · R37 AI033443 · United States
NIAMS NIH HHS · P30 AR058886 · United States
NIAID NIH HHS · R01 AI068977 · United States
NIAID NIH HHS · AI033443 · United States
NIAID NIH HHS · R01 AI033443 · United States
NIAID NIH HHS · R01 AI093985 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com